Lynas Rare Earths Limited (LYSCF) — Earnings Call X-Ray
Our AI read all 28 of LYSCF's earnings calls (2020–2025) and answered the same battery of questions about each one. Every past call is free; the newest quarter unlocks with a free account.
Previous Call Grade
D
Q3 2025
Calls Analyzed
28
2020–2025
Avg Candor
6.8/9
evasion 3.6/9
Call-by-call analysis
🔒 Q4 2025 earnings call
2025-07-24
NEWEST
Guidance: ■■■■■Demand: ■■■■■■
Margins: ■■■■Backlog: ■■■■
■ analysts, ■■ questionsexpected move ±■■%
Management ■■■■■■ guidance against ■■■■■■■■ demand and ■■■■■■■ margins. The delivery was ■■■■■■■■ and ■■■■ in specifics, with ■■■ questions left hanging.
🔒 The Q4 2025 call grade is ready
The full 37-point AI read of LYSCF's newest earnings call — grade, expected move, and every question answered — is free with an account.
Sign up free to unlock
D
Q3 2025 earnings call
2025-04-28
move ±12.4%
Management gave no formal guidance against accelerating demand. The delivery was unusually candid.
Demand: acceleratingPricing: raisingCapex: decreasing 12 analysts · 20 questions
⚑ Critic ammunition✓ Skeptic reassured⚑ Question left hanging✓ Resolves doubts✓ Early product, fast growthDirection beats results
All 20 questions our AI answered about this call
YES Would a skeptical short-seller find this call reassuring?
NO Would a careful investor underwrite management's guidance?
YES Is management's confidence proportionate to the evidence presented?
YES Does the call resolve more doubts than it creates?
YES Is there something a critic could fairly use against the company?
NO Is a claimed advantage dependent on scale they lack?
YES Does an obvious question remain unanswered?
YES Is a product early in its life but growing very fast?
NO Do they serve a small fraction of their addressable customers?
NO Is volume about to step up rather than grow gradually?
YES Are high fixed costs currently underutilised?
YES Is pricing recovering from a depressed level?
YES Do current results look bad while the direction looks better?
NO Are deferred revenue or customer prepayments growing?
NO Is consolidation happening among their peers?
NO Is a founder still running the company?
NO Does the final speaker sound like they are summarizing a finished story?
NO Is a fast-growing segment obscured by a declining one?
NO Does the CFO speak more than the CEO?
NO Does the call read rehearsed rather than lived?
C
Q2 2025 earnings call
2025-02-26
move ±9.6%
Management held guidance steady against mixed demand signals and contracting margins. The delivery was rich in specifics.
Guidance: maintainedDemand: mixedMargins: contractingPricing: under pressureCapex: increasing 8 analysts · 11 questions
⚑ Critic ammunition✓ Skeptic reassured✓ Guidance underwritable✓ Resolves doubts✓ Volume step-up aheadDirection beats results
All 20 questions our AI answered about this call
YES Would a skeptical short-seller find this call reassuring?
YES Would a careful investor underwrite management's guidance?
YES Is management's confidence proportionate to the evidence presented?
YES Does the call resolve more doubts than it creates?
YES Is there something a critic could fairly use against the company?
NO Is a claimed advantage dependent on scale they lack?
NO Does an obvious question remain unanswered?
NO Is a product early in its life but growing very fast?
NO Do they serve a small fraction of their addressable customers?
YES Is volume about to step up rather than grow gradually?
YES Are high fixed costs currently underutilised?
YES Is pricing recovering from a depressed level?
YES Do current results look bad while the direction looks better?
NO Are deferred revenue or customer prepayments growing?
YES Is consolidation happening among their peers?
NO Is a founder still running the company?
NO Does the final speaker sound like they are summarizing a finished story?
NO Is a fast-growing segment obscured by a declining one?
NO Does the CFO speak more than the CEO?
NO Does the call read rehearsed rather than lived?
C
Q1 2025 earnings call
2024-11-02
move ±9.3%
Management held guidance steady against steady demand and contracting margins. The delivery was unusually candid.
Guidance: maintainedDemand: stableMargins: contractingPricing: stableCapex: increasing 7 analysts · 19 questions
⚑ Critic ammunition✓ Skeptic reassured✓ Guidance underwritable✓ Resolves doubts✓ Volume step-up aheadDirection beats results
All 20 questions our AI answered about this call
YES Would a skeptical short-seller find this call reassuring?
YES Would a careful investor underwrite management's guidance?
YES Is management's confidence proportionate to the evidence presented?
YES Does the call resolve more doubts than it creates?
YES Is there something a critic could fairly use against the company?
NO Is a claimed advantage dependent on scale they lack?
NO Does an obvious question remain unanswered?
NO Is a product early in its life but growing very fast?
NO Do they serve a small fraction of their addressable customers?
YES Is volume about to step up rather than grow gradually?
YES Are high fixed costs currently underutilised?
YES Is pricing recovering from a depressed level?
YES Do current results look bad while the direction looks better?
NO Are deferred revenue or customer prepayments growing?
NO Is consolidation happening among their peers?
NO Is a founder still running the company?
NO Does the final speaker sound like they are summarizing a finished story?
NO Is a fast-growing segment obscured by a declining one?
NO Does the CFO speak more than the CEO?
NO Does the call read rehearsed rather than lived?
C
Q4 2024 earnings call
2024-08-28
move ±11.6%
Management gave no formal guidance against mixed demand signals and contracting margins. The delivery was unusually candid, rich in specifics.
Demand: mixedMargins: contractingPricing: under pressureCapex: increasing 9 analysts · 14 questions
⚑ Critic ammunition⚑ Question left hanging✓ Guidance underwritable✓ Resolves doubts✓ Volume step-up aheadDirection beats results
All 20 questions our AI answered about this call
NO Would a skeptical short-seller find this call reassuring?
YES Would a careful investor underwrite management's guidance?
YES Is management's confidence proportionate to the evidence presented?
YES Does the call resolve more doubts than it creates?
YES Is there something a critic could fairly use against the company?
NO Is a claimed advantage dependent on scale they lack?
YES Does an obvious question remain unanswered?
NO Is a product early in its life but growing very fast?
NO Do they serve a small fraction of their addressable customers?
YES Is volume about to step up rather than grow gradually?
YES Are high fixed costs currently underutilised?
YES Is pricing recovering from a depressed level?
YES Do current results look bad while the direction looks better?
NO Are deferred revenue or customer prepayments growing?
NO Is consolidation happening among their peers?
NO Is a founder still running the company?
NO Does the final speaker sound like they are summarizing a finished story?
NO Is a fast-growing segment obscured by a declining one?
NO Does the CFO speak more than the CEO?
NO Does the call read rehearsed rather than lived?
D
Q4 2024 earnings call
2024-07-23
move ±8.9%
Management held guidance steady against slowing demand and contracting margins. The delivery was unusually candid.
Guidance: maintainedDemand: slowingMargins: contractingPricing: under pressureCapex: decreasing 9 analysts · 23 questions
⚑ Critic ammunition⚑ Question left hanging✓ Guidance underwritableDirection beats results
All 20 questions our AI answered about this call
NO Would a skeptical short-seller find this call reassuring?
YES Would a careful investor underwrite management's guidance?
YES Is management's confidence proportionate to the evidence presented?
NO Does the call resolve more doubts than it creates?
YES Is there something a critic could fairly use against the company?
NO Is a claimed advantage dependent on scale they lack?
YES Does an obvious question remain unanswered?
NO Is a product early in its life but growing very fast?
NO Do they serve a small fraction of their addressable customers?
NO Is volume about to step up rather than grow gradually?
YES Are high fixed costs currently underutilised?
NO Is pricing recovering from a depressed level?
YES Do current results look bad while the direction looks better?
NO Are deferred revenue or customer prepayments growing?
YES Is consolidation happening among their peers?
NO Is a founder still running the company?
NO Does the final speaker sound like they are summarizing a finished story?
NO Is a fast-growing segment obscured by a declining one?
NO Does the CFO speak more than the CEO?
NO Does the call read rehearsed rather than lived?
C
Q3 2024 earnings call
2024-04-24
move ±9.9%
Management held guidance steady against mixed demand signals and contracting margins. The delivery was unusually candid, rich in specifics.
Guidance: maintainedDemand: mixedMargins: contractingPricing: under pressureCapex: increasing 9 analysts · 28 questions
⚑ Critic ammunition⚑ Question left hanging✓ Guidance underwritable✓ Resolves doubts✓ Volume step-up aheadDirection beats results
All 20 questions our AI answered about this call
NO Would a skeptical short-seller find this call reassuring?
YES Would a careful investor underwrite management's guidance?
YES Is management's confidence proportionate to the evidence presented?
YES Does the call resolve more doubts than it creates?
YES Is there something a critic could fairly use against the company?
NO Is a claimed advantage dependent on scale they lack?
YES Does an obvious question remain unanswered?
NO Is a product early in its life but growing very fast?
NO Do they serve a small fraction of their addressable customers?
YES Is volume about to step up rather than grow gradually?
YES Are high fixed costs currently underutilised?
YES Is pricing recovering from a depressed level?
YES Do current results look bad while the direction looks better?
NO Are deferred revenue or customer prepayments growing?
NO Is consolidation happening among their peers?
NO Is a founder still running the company?
NO Does the final speaker sound like they are summarizing a finished story?
NO Is a fast-growing segment obscured by a declining one?
NO Does the CFO speak more than the CEO?
NO Does the call read rehearsed rather than lived?
C+
Q2 2024 earnings call
2024-02-26
move ±9.4%
Management held guidance steady against slowing demand and contracting margins. The delivery was unusually candid, rich in specifics.
Guidance: maintainedDemand: slowingMargins: contractingPricing: under pressureCapex: increasing 7 analysts · 18 questions
⚑ Critic ammunition✓ Guidance underwritable✓ Resolves doubts✓ Volume step-up aheadDirection beats results
All 20 questions our AI answered about this call
NO Would a skeptical short-seller find this call reassuring?
YES Would a careful investor underwrite management's guidance?
YES Is management's confidence proportionate to the evidence presented?
YES Does the call resolve more doubts than it creates?
YES Is there something a critic could fairly use against the company?
NO Is a claimed advantage dependent on scale they lack?
NO Does an obvious question remain unanswered?
NO Is a product early in its life but growing very fast?
NO Do they serve a small fraction of their addressable customers?
YES Is volume about to step up rather than grow gradually?
YES Are high fixed costs currently underutilised?
NO Is pricing recovering from a depressed level?
YES Do current results look bad while the direction looks better?
NO Are deferred revenue or customer prepayments growing?
YES Is consolidation happening among their peers?
NO Is a founder still running the company?
NO Does the final speaker sound like they are summarizing a finished story?
NO Is a fast-growing segment obscured by a declining one?
NO Does the CFO speak more than the CEO?
NO Does the call read rehearsed rather than lived?
From the research question bank
11 more research questions answered NO
Earlier calls
| Call | Date | Grade | Guidance | Demand | Margins | Candor | Evasion |
|---|
| Q2 2024 |
2024-01-22 |
F |
maintained | slowing | contracting |
6/9 |
5/9 |
| Q1 2024 |
2023-10-19 |
F |
maintained | stable | unclear |
6/9 |
5/9 |
| Q4 2023 |
2023-08-29 |
C |
raised | slowing | contracting |
7/9 |
4/9 |
| Q4 2023 |
2023-07-31 |
D |
maintained | mixed | contracting |
7/9 |
3/9 |
| Q3 2023 |
2023-04-21 |
F |
lowered | stable | contracting |
6/9 |
5/9 |
| Q2 2023 |
2023-02-27 |
F |
maintained | stable | contracting |
6/9 |
5/9 |
| Q4 2022 |
2023-01-30 |
D |
none | accelerating | stable |
6/9 |
5/9 |
| Q1 2023 |
2022-10-27 |
C |
maintained | stable | contracting |
7/9 |
2/9 |
| Q4 2022 |
2022-07-18 |
C+ |
maintained | stable | contracting |
7/9 |
2/9 |
| Q1 2022 |
2022-04-12 |
B |
maintained | accelerating | expanding |
7/9 |
2/9 |
| Q4 2021 |
2022-01-18 |
C+ |
maintained | accelerating | expanding |
7/9 |
2/9 |
| Q1 2022 |
2021-10-22 |
D |
maintained | accelerating | unclear |
7/9 |
3/9 |
| Q4 2021 |
2021-07-26 |
D |
none | accelerating | expanding |
6/9 |
5/9 |
| Q3 2021 |
2021-04-20 |
C+ |
maintained | accelerating | expanding |
7/9 |
3/9 |
| Feb 2021 |
2021-02-26 |
D |
maintained | accelerating | expanding |
6/9 |
4/9 |
| Q2 2021 |
2021-01-29 |
C |
maintained | accelerating | expanding |
6/9 |
4/9 |
| Q1 2021 |
2020-10-21 |
C+ |
maintained | stable | stable |
7/9 |
2/9 |
| Q4 2020 |
2020-08-17 |
B |
maintained | stable | stable |
8/9 |
2/9 |
| Q4 2020 |
2020-07-22 |
C |
none | mixed | contracting |
8/9 |
5/9 |
| Q3 2020 |
2020-04-15 |
C |
none | slowing | unclear |
7/9 |
3/9 |
How to read this page
The grade is a transparent composite of call quality — candor, specificity, low evasion, low stress, whether the call resolves more doubts than it creates, and the guidance action — not a buy or sell signal. The expected move is a volatility estimate from the one signal that survived our out-of-sample tests: how a stock's own reaction and pre-call volatility predict the size (not direction) of its next move. Full detail, including everything that failed: methodology.
Companies with similar call quality
← LYRA All “L” companies
LYSDY →
Not investment advice. Artul.ai publishes AI-generated earnings-call quality grades and expected-volatility estimates — never buy or sell recommendations. We tested over 1,600 predictive hypotheses against 165,000 transcripts; the honest result, including what failed, is documented in our
methodology.